nafoxidine has been researched along with Breast Neoplasms in 59 studies
Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized clinical trial of nafoxidine, a non-steroidal oestrogen antagonist, and ethinyloestradiol in postmenopausal patients with advanced breast cancer produced objective remissions in 31% of 49 women receiving nafoxidine and in 14% of 49 receiving ethinyloestradiol." | 9.04 | Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study. ( Blonk-Van Der Wijst, J; Drochmans, A; Engelsman, E; Gorins, A; Heuson, JC; Maass, H; Michel, J; Nowakowski, H, 1975) |
| "Effects of tamoxifen (TAM), nafoxidine (NFA), 4-hydroxytamoxifen (4-OH-TAM), 3-hydroxytamoxifen (3-OH-TAM), and medroxyprogesterone acetate (MPA) on the clonogenic growth of a hormone-responsive human breast cancer cell line (MCF-7) and its tamoxifen-resistant variant (R-27) were studied." | 7.67 | [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells]. ( Nomura, Y; Takaeko, F; Tashiro, H, 1985) |
| "Forty-nine postmenopausal patients with advanced breast cancer were treated with a nonsteroidal antiestrogen, Nafoxidine." | 7.66 | Clinical trial of nafoxidine in advanced breast cancer. ( De Jager, RL; Krakoff, IH; Steinbaum, FL, 1978) |
| "The synthetic non-steroidal antioestrogen nafoxidine (U-11, 100A) was given by mouth to 52 women with locally advanced or metastatic breast cancer, in 85% of whom the disease had become resistant to, or relapsed after, previous endocrine treatment." | 7.65 | Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases. ( Bloom, HJ; Boesen, E, 1974) |
| "In patients with metastatic breast carcinoma, who have undergone adrenalectomy in the past, a therapeutic trial with Nafoxidine may be worthwhile particularly in patients who have demonstrable estrogen receptor in the tumor of those who have in the past shown regression of tumor after endocrine therapy." | 6.64 | Clinical trial of nafoxidine in adrenalectomized patients with advanced breast cancer. ( Jain, J; Samal, B; Singhakowinta, A; Vaitkevicius, VK, 1977) |
| "Nafoxidine is a nonsteroidal antiestrogen available as an investigational agent from the Investigational Drug Branch of the National Cancer Institute." | 5.26 | Nafoxidine--an antiestrogen for the treatment of breast cancer. ( Carter, SK; Legha, SS; Slavik, M, 1976) |
| "A randomized clinical trial of nafoxidine, a non-steroidal oestrogen antagonist, and ethinyloestradiol in postmenopausal patients with advanced breast cancer produced objective remissions in 31% of 49 women receiving nafoxidine and in 14% of 49 receiving ethinyloestradiol." | 5.04 | Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study. ( Blonk-Van Der Wijst, J; Drochmans, A; Engelsman, E; Gorins, A; Heuson, JC; Maass, H; Michel, J; Nowakowski, H, 1975) |
| "The most useful new hormonal therapy against estrogen receptor-containing metastatic breast cancer is the development of antiestrogenic agents such as nafoxidine and tamoxifen." | 4.75 | Hormonal therapy of breast cancer: new approaches and concepts. ( Davis, HL; Legha, SS; Muggia, FM, 1978) |
| "The effects of estradiol and antiestrogens on two estrogen-regulated proteins (52 and 160 kDa) and an estrogen-inducible mRNA (pS2) have been measured in the MCF7 human breast cancer cell line and two tamoxifen-resistant sublines." | 3.67 | Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. ( Brown, AM; Chambon, P; Krust, A; Lippman, ME; May, FE; Rochefort, H; Westley, B, 1984) |
| "Effects of tamoxifen (TAM), nafoxidine (NFA), 4-hydroxytamoxifen (4-OH-TAM), 3-hydroxytamoxifen (3-OH-TAM), and medroxyprogesterone acetate (MPA) on the clonogenic growth of a hormone-responsive human breast cancer cell line (MCF-7) and its tamoxifen-resistant variant (R-27) were studied." | 3.67 | [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells]. ( Nomura, Y; Takaeko, F; Tashiro, H, 1985) |
| "Forty-nine postmenopausal patients with advanced breast cancer were treated with a nonsteroidal antiestrogen, Nafoxidine." | 3.66 | Clinical trial of nafoxidine in advanced breast cancer. ( De Jager, RL; Krakoff, IH; Steinbaum, FL, 1978) |
| "Human breast cancer was studied by in vitro techniques on tissue slices and extracts for a specific binding of estradiol and dihydrotestosterone." | 3.65 | Steroid hormone receptors in human breast cancer and clinical correlations. ( Engel, B; Maass, H; Nowakowski, H; Stolzenbach, G; Trams, G, 1975) |
| ", nafoxidine, tamoxifen, and clomiphene, have been reported to induce objective clinical remissions in patients with breast cancer." | 3.65 | Letter: Antiestrogens in the treatment of cancer. ( Legha, S; Muggia, FM, 1976) |
| "The synthetic non-steroidal antioestrogen nafoxidine (U-11, 100A) was given by mouth to 52 women with locally advanced or metastatic breast cancer, in 85% of whom the disease had become resistant to, or relapsed after, previous endocrine treatment." | 3.65 | Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases. ( Bloom, HJ; Boesen, E, 1974) |
| "In patients with metastatic breast carcinoma, who have undergone adrenalectomy in the past, a therapeutic trial with Nafoxidine may be worthwhile particularly in patients who have demonstrable estrogen receptor in the tumor of those who have in the past shown regression of tumor after endocrine therapy." | 2.64 | Clinical trial of nafoxidine in adrenalectomized patients with advanced breast cancer. ( Jain, J; Samal, B; Singhakowinta, A; Vaitkevicius, VK, 1977) |
| "In T47D breast cancer cells, the NBD-progestin showed receptor-mediated uptake and nuclear localization." | 1.28 | Receptor binding of NBD-labeled fluorescent estrogens and progestins in whole cells and cell-free preparations. ( Carlson, KE; Coppey, M; Katzenellenbogen, JA; Magdelenat, H, 1989) |
| "In human breast cancer the proliferating cells appear to differ from those containing estrogen receptors (ER) as shown by studies on isolated cellular subpopulations." | 1.27 | In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer. ( Bover, L; Bravo, AI; Dain, L; Guman, N; Mordoh, J; Podhajcer, OL, 1988) |
| "Patients with advanced breast cancer may develop acute, severe hypercalcemia when treated with estrogens or antiestrogens." | 1.27 | Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells. ( Eilon, G; Mundy, GR; Saez, S; Valentin-Opran, A, 1985) |
| "We describe studies with T47D human breast cancer cells, whose PRs are not regulated by estradiol, though present in extraordinary amounts (300,000 sites per cell)." | 1.26 | Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. ( Horwitz, KB; Lessey, BA; Mockus, MB, 1982) |
| "The human breast cancer cell line MCF-7 does not require estrogen for growth, but paradoxically its growth is inhibited by antiestrogens." | 1.26 | Human breast cancer: biologically active estrogen receptor in the absence of estrogen? ( Chamness, GC; Horwitz, KB; McGuire, WL; Zava, DT, 1977) |
| "We have used human breast cancer cells in long term culture as an in vitro model to study the roles of estradiol and the antiestrogens, tamoxifen and nafoxidine, on cell growth and progesterone receptor (PgR) induction." | 1.26 | Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. ( Horwitz, KB; Koseki, Y; McGuire, WL, 1978) |
| "Nafoxidine is a nonsteroidal antiestrogen available as an investigational agent from the Investigational Drug Branch of the National Cancer Institute." | 1.26 | Nafoxidine--an antiestrogen for the treatment of breast cancer. ( Carter, SK; Legha, SS; Slavik, M, 1976) |
| "The presence of estrogen receptors in human mammary carcinomas has a distinct correlation with the response to adrenalectomy." | 1.25 | Human breast cancer and estrogen receptor. ( Cleton, FJ; Engelsman, E; Korsten, CB; Persijn, JP, 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 56 (94.92) | 18.7374 |
| 1990's | 3 (5.08) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosati, RL | 1 |
| Da Silva Jardine, P | 1 |
| Cameron, KO | 1 |
| Thompson, DD | 1 |
| Ke, HZ | 1 |
| Toler, SM | 1 |
| Brown, TA | 1 |
| Pan, LC | 1 |
| Ebbinghaus, CF | 1 |
| Reinhold, AR | 1 |
| Elliott, NC | 1 |
| Newhouse, BN | 1 |
| Tjoa, CM | 1 |
| Sweetnam, PM | 1 |
| Cole, MJ | 1 |
| Arriola, MW | 1 |
| Gauthier, JW | 1 |
| Crawford, DT | 1 |
| Nickerson, DF | 1 |
| Pirie, CM | 1 |
| Qi, H | 1 |
| Simmons, HA | 1 |
| Tkalcevic, GT | 1 |
| van Marle, J | 1 |
| Lindeman, J | 1 |
| Ariens, AT | 1 |
| Labruyère, W | 1 |
| van Weeren-Kramer, J | 1 |
| Westley, B | 1 |
| May, FE | 1 |
| Brown, AM | 1 |
| Krust, A | 1 |
| Chambon, P | 1 |
| Lippman, ME | 2 |
| Rochefort, H | 1 |
| Eckert, RL | 1 |
| Mullick, A | 1 |
| Rorke, EA | 1 |
| Katzenellenbogen, BS | 1 |
| Osborne, CK | 1 |
| Boldt, DH | 1 |
| Estrada, P | 1 |
| Adams, DJ | 3 |
| Hajj, H | 1 |
| Edwards, DP | 4 |
| Bjercke, RJ | 1 |
| McGuire, WL | 11 |
| Horwitz, KB | 7 |
| Syne, JS | 1 |
| Markaverich, BM | 1 |
| Clark, JH | 1 |
| Panko, WB | 1 |
| Aiginger, P | 1 |
| Kuttenn, F | 1 |
| Mockus, MB | 1 |
| Lessey, BA | 1 |
| Stoll, BA | 2 |
| Murthy, SR | 1 |
| Savage, N | 1 |
| Strobl, JS | 1 |
| Monaco, ME | 1 |
| Brooks, SC | 1 |
| Saunders, DE | 1 |
| Singhakowinta, A | 2 |
| Vaitkevicius, VK | 2 |
| Wiseman, H | 1 |
| Halliwell, B | 1 |
| Poortman, J | 1 |
| Prenen, JA | 1 |
| Schwarz, F | 1 |
| Thijssen, JH | 1 |
| Bolt, HM | 1 |
| Braunsberg, H | 1 |
| Carbone, PP | 1 |
| Maass, H | 3 |
| Engel, B | 1 |
| Nowakowski, H | 3 |
| Stolzenbach, G | 1 |
| Trams, G | 1 |
| Görlich, M | 2 |
| Heise, E | 2 |
| Zava, DT | 3 |
| Chamness, GC | 2 |
| Tagnon, HJ | 1 |
| Jain, J | 1 |
| Samal, B | 1 |
| Legha, SS | 3 |
| Davis, HL | 1 |
| Muggia, FM | 2 |
| Számel, I | 1 |
| Kerpel-Fronius, S | 1 |
| Mulder, J | 1 |
| Verhaar, MA | 1 |
| McIntosh, IH | 1 |
| Thynne, GS | 1 |
| Metz, R | 1 |
| Bey, P | 1 |
| Moseson, DL | 1 |
| Sasaki, GH | 2 |
| Kraybill, WG | 1 |
| Leung, BS | 2 |
| Davenport, CE | 1 |
| Fletcher, WS | 2 |
| Steinbaum, FL | 1 |
| De Jager, RL | 1 |
| Krakoff, IH | 1 |
| Burke, RE | 1 |
| Mira, JG | 1 |
| Datta, R | 1 |
| Garola, RE | 1 |
| Koseki, Y | 1 |
| Heuson, JC | 4 |
| Longeval, E | 1 |
| Mattheiem, WH | 1 |
| Deboel, MC | 1 |
| Sylvester, RJ | 1 |
| Leclercq, G | 1 |
| Legha, S | 1 |
| Slavik, M | 1 |
| Carter, SK | 2 |
| Engelsman, E | 5 |
| Blonk-Van Der Wijst, J | 1 |
| Drochmans, A | 2 |
| Michel, J | 1 |
| Gorins, A | 2 |
| Blonk Van Der Wijst, J | 1 |
| Cheix, F | 1 |
| Sobrinho, LG | 1 |
| Eskenazi, F | 1 |
| Lopes, MC | 1 |
| Tavares, MC | 1 |
| Vale, MG | 1 |
| Carvalho, AP | 1 |
| Carlson, KE | 1 |
| Coppey, M | 1 |
| Magdelenat, H | 1 |
| Katzenellenbogen, JA | 1 |
| Kida, N | 1 |
| Yoshimura, T | 1 |
| Mori, K | 1 |
| Hayashi, K | 1 |
| Nomura, Y | 1 |
| Tashiro, H | 1 |
| Takaeko, F | 1 |
| Podhajcer, OL | 1 |
| Bravo, AI | 1 |
| Dain, L | 1 |
| Guman, N | 1 |
| Bover, L | 1 |
| Mordoh, J | 1 |
| Valentin-Opran, A | 1 |
| Eilon, G | 1 |
| Saez, S | 1 |
| Mundy, GR | 1 |
| Santa Cruz, AR | 1 |
| Medrano, EE | 1 |
| Baldi, A | 1 |
| Korsten, CB | 2 |
| Persijn, JP | 2 |
| Cleton, FJ | 2 |
| Bloom, HJ | 1 |
| Boesen, E | 1 |
| L'Hermite, M | 1 |
| Robyn, C | 1 |
| Rozencweig, M | 1 |
3 reviews available for nafoxidine and Breast Neoplasms
| Article | Year |
|---|---|
Studies on mechanisms of estrogen and antiestrogen action in human breast cancer.
Topics: Breast Neoplasms; Cell Line; Cell Nucleus; Cytoplasm; Dactinomycin; Dose-Response Relationship, Drug | 1980 |
Antiestrogens in treatment of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Clomiphene; Estrogen Antagonists; Ethinyl E | 1977 |
Hormonal therapy of breast cancer: new approaches and concepts.
Topics: Adrenalectomy; Breast Neoplasms; Castration; Clomiphene; Ergotamines; Estrogen Antagonists; Female; | 1978 |
5 trials available for nafoxidine and Breast Neoplasms
| Article | Year |
|---|---|
Antiestrogens in treatment of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Clomiphene; Estrogen Antagonists; Ethinyl E | 1977 |
Clinical trial of nafoxidine in adrenalectomized patients with advanced breast cancer.
Topics: Adrenalectomy; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; F | 1977 |
Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Ethinyl Estradiol; Fe | 1975 |
Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Levod | 1975 |
Letter: Breast cancer regression under oestrogen therapy.
Topics: Aged; Breast Neoplasms; Estrogens; Ethinyl Estradiol; Female; Humans; Menopause; Middle Aged; Nafoxi | 1974 |
52 other studies available for nafoxidine and Breast Neoplasms
| Article | Year |
|---|---|
Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene.
Topics: Administration, Oral; Animals; Biological Availability; Bone Density; Breast Neoplasms; Cell Divisio | 1998 |
Estrogen receptors in human breast cancer. I. Specificity of the histochemical localization of estrogen receptors using an estrogen-albumin FITC complex.
Topics: Animals; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Estrogens; Fluorescein-5-isothio | 1982 |
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines.
Topics: Breast Neoplasms; Cell Line; Drug Resistance; Estradiol; Estrogen Antagonists; Female; Humans; Kinet | 1984 |
Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique.
Topics: Breast Neoplasms; Cell Line; Cell Nucleus; Centrifugation, Density Gradient; Cytosol; Female; Humans | 1984 |
Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
Topics: Breast Neoplasms; Cell Cycle; Cell Line; Culture Media; Estradiol; Estrogen Antagonists; Female; Hum | 1984 |
Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Antigen-Antibody Complex; Biopsy; Breast Neoplasms; Cell Line; Elec | 1983 |
Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
Topics: Breast Neoplasms; Cell Nucleus; Cytosol; DNA, Neoplasm; Estradiol; Female; Humans; Kinetics; Myometr | 1982 |
Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Cell Nucleus; Dactinomycin; Estradiol; Female; Humans; Kinetics; Nafoxi | 1981 |
Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.
Topics: Breast Neoplasms; Bromodeoxyuridine; Butyrates; Cell Nucleus; Cells, Cultured; Cycloheximide; Cytopl | 1982 |
Estrogen regulation of specific messinger RNA's in human breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Estradiol; Female; Humans; Molecular Weight; Nafoxidine; Neoplasm Prote | 1980 |
Clinical experience with tamoxifen in advanced breast cancer.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Clomiphene; Drug Tolerance; Female; Humans; Hypercalcemi | 1980 |
Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer.
Topics: Breast Neoplasms; Cell Division; Cell Line; DNA-Directed DNA Polymerase; Dose-Response Relationship, | 1980 |
Estrogen induced synthesis of specific proteins in human breast cancer cells.
Topics: Breast Neoplasms; Carbon Radioisotopes; Cell Line; Estradiol; Female; Humans; Kinetics; Leucine; Naf | 1980 |
The role of intracellular equilibria and the effect of antiestrogens on estrogen-receptor dissociation kinetics from perfused cultures of human breast cancer cells.
Topics: Binding Sites; Breast Neoplasms; Cell Line; Clomiphene; Estradiol; Estriol; Female; Humans; Kinetics | 1980 |
Relation of tumor content of estrogen and progesterone receptors with response of patient to endocrine therapy.
Topics: Breast Neoplasms; Diethylstilbestrol; Estrogen Antagonists; Female; Humans; Nafoxidine; Neoplasms, H | 1980 |
Tamoxifen and related compounds protect against lipid peroxidation in isolated nuclei: relevance to the potential anticarcinogenic benefits of breast cancer prevention and therapy with tamoxifen?
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Cell Nucleus; Estradiol; Estrogen Antagonists; F | 1994 |
Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
Topics: Adult; Aged; Androstenediols; Androstenedione; Binding, Competitive; Breast Neoplasms; Cyproterone; | 1975 |
[The importance of estrogen receptors in the pharmacotherapy of mammary carcinoma (author's transl)].
Topics: Androgens; Breast Neoplasms; Castration; Cytoplasm; Estrogen Antagonists; Estrogens; Female; Humans; | 1975 |
Factors influencing the estimation of oestrogen receptors in human malignant breast tumours.
Topics: Breast Neoplasms; Cytosol; Estradiol; Freezing; Humans; Nafoxidine; Nitromifene; Receptors, Cell Sur | 1975 |
Editorial: Antiestrogens and breast cancer treatment.
Topics: Breast Neoplasms; Estrogen Antagonists; Female; Humans; Nafoxidine; Receptors, Cell Surface; Tamoxif | 1975 |
Steroid hormone receptors in human breast cancer and clinical correlations.
Topics: Adult; Aged; Breast Neoplasms; Castration; Dihydrotestosterone; Estradiol; Female; Humans; Menopause | 1975 |
Estradiol receptor activity in tissues of human breast cancer.
Topics: Androstanols; Breast Neoplasms; Estradiol; Female; Humans; Lymph Nodes; Menopause; Nafoxidine; Progn | 1975 |
Human breast cancer: biologically active estrogen receptor in the absence of estrogen?
Topics: Breast Neoplasms; Cell Division; Cell Line; Cell Nucleus; Cytoplasm; Estradiol; Nafoxidine; Neoplasm | 1977 |
Chemotherapeutic agents and estradiol receptor binding capacity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Dianhydrogalactitol; Estradiol; Female; | 1979 |
Estrogen control of progesterone receptor induction in human breast cancer: role of nuclear estrogen receptor.
Topics: Breast Neoplasms; Cell Line; Cell Nucleus; Cytoplasm; Estradiol; Female; Humans; Nafoxidine; Recepto | 1979 |
A comparative study on estradiol receptor assays in human breast cancer tissue.
Topics: Binding, Competitive; Breast Neoplasms; Cytosol; Estradiol; Female; Humans; Kinetics; Nafoxidine; Re | 1979 |
Tumour stimulation by anti-oestrogens.
Topics: Adult; Breast Neoplasms; Female; Humans; Middle Aged; Nafoxidine; Pyrrolidines; Recurrence; Tamoxife | 1977 |
[Treatment of breast cancers with antiestrogens. Clinical study of nafoxidine].
Topics: Breast Neoplasms; Female; Humans; Nafoxidine; Pyrrolidines | 1977 |
The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values. A phase II study.
Topics: Breast Neoplasms; Female; Humans; Nafoxidine; Pyrrolidines; Receptors, Estrogen; Tamoxifen | 1978 |
Clinical trial of nafoxidine in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Mid | 1978 |
Estrogen action following irradiation of human breast cancer cells.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Line; Estradiol; Gamma Rays; Humans; Nafoxidine; Neoplasms, E | 1978 |
Receptors and breast cancer: do we know it all?
Topics: Breast Neoplasms; Cell Nucleus; Cells, Cultured; Cytosol; Dihydrotestosterone; Estradiol; Female; Hu | 1978 |
Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen.
Topics: Breast Neoplasms; Cells, Cultured; Estradiol; Estrogen Antagonists; Humans; Nafoxidine; Receptors, P | 1978 |
Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer.
Topics: Adrenalectomy; Adult; Aged; Androgens; Breast Neoplasms; Castration; Ethinyl Estradiol; Female; Huma | 1977 |
Letter: Antiestrogens in the treatment of cancer.
Topics: Breast Neoplasms; Clomiphene; Estrogen Antagonists; Female; Hormone Antagonists; Humans; Male; Nafox | 1976 |
Nafoxidine--an antiestrogen for the treatment of breast cancer.
Topics: Animals; Breast Neoplasms; Drug Evaluation; Drug Evaluation, Preclinical; Female; Humans; Ichthyosis | 1976 |
Antiestrogens in the treatment of breast cancer.
Topics: Breast Neoplasms; Clomiphene; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Humans | 1976 |
[Further aspects of hormone therapy of metastatic breast cancer].
Topics: Breast Neoplasms; Estrogen Antagonists; Female; Humans; Nafoxidine; Prolactin; Pyrrolidines; Stilben | 1975 |
Therapeutic value of nafoxidine hydrochloride in the treatment of advanced carcinoma of the human breast.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Midd | 1976 |
Characterization of estrogen and antiestrogen binding to the cytosol and microsomes of breast tumors.
Topics: Binding, Competitive; Breast Neoplasms; Clomiphene; Cytosol; Enclomiphene; Estrogen Antagonists; Est | 1991 |
Receptor binding of NBD-labeled fluorescent estrogens and progestins in whole cells and cell-free preparations.
Topics: Affinity Labels; Binding, Competitive; Breast Neoplasms; Cell Line; Cell Nucleus; Cytoplasm; Estradi | 1989 |
Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7).
Topics: Androgens; Breast Neoplasms; Cell Division; Cycloheximide; Dactinomycin; DNA, Neoplasm; Estrogens; H | 1989 |
[Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
Topics: Breast Neoplasms; Cell Division; Cell Line; Cells, Cultured; Drug Resistance; Estrogen Antagonists; | 1985 |
In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer.
Topics: Breast Neoplasms; Carcinoembryonic Antigen; Cell Division; Diethylstilbestrol; DNA Replication; DNA, | 1988 |
Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.
Topics: Biological Products; Bone Resorption; Breast Neoplasms; Cells, Cultured; Cytokines; Dinoprostone; Es | 1985 |
Dolichol-sugar derivative synthesis in human breast cancer cell line (T47D). Effects of estrogens and antiestrogens.
Topics: Breast Neoplasms; Cell Line; Chromatography, Ion Exchange; Chromatography, Thin Layer; Estradiol; Fe | 1985 |
Letter: Anti-oestrogens and breast cancer.
Topics: Biopsy; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Nafoxidine; Pyrrolidines; Remission, | 1974 |
Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases.
Topics: Adult; Aged; Breast Neoplasms; Cataract; Estrogen Antagonists; Female; Humans; Hypophysectomy; Menop | 1974 |
Antioestrogens in treatment of breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Dimethylamines; Estrogen Antagonists; Female; Humans; Menop | 1974 |
Proceedings: Clinical value of predictive tests for advanced breast cancer.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Androgens; Breast Neoplasms; Castration; Estradiol; Estrogen | 1974 |
Human breast cancer and estrogen receptor.
Topics: Adrenalectomy; Breast Neoplasms; Castration; Estrogens; Ethinyl Estradiol; Female; Humans; Hypophyse | 1973 |
Letter: Antioestrogens in treatment of breast cancer.
Topics: Breast Neoplasms; Estrogen Antagonists; Female; Humans; Menopause; Nafoxidine; Pyrrolidines | 1974 |